[Federal Register Volume 68, Number 188 (Monday, September 29, 2003)]
[Notices]
[Pages 56016-56017]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-24531]


=======================================================================
-----------------------------------------------------------------------

NATIONAL AERONAUTICS AND SPACE ADMINISTRATION

[Notice (03-116)]


Notice of Prospective Patent License

AGENCY: National Aeronautics and Space Administration.

ACTION: Notice of prospective patent license.

-----------------------------------------------------------------------

SUMMARY: NASA hereby gives notice that Regenetech, Inc., of Sugar Land, 
TX, has applied for a partially exclusive license to practice the 
inventions described and claimed in U.S. Patent No. 6,485,963, ``Growth 
Stimulation of Biological Cells and Tissue by Electromagnetic Fields 
and Uses Thereof; U.S. Patent No. 5,153,132, entitled ``Three-
Dimensional Co-Culture Process;'' U.S. Patent No. 5,153,133, entitled 
``Method for Culturing Mammalian Cells in a Horizontally Rotated 
Bioreactor;'' U.S. Patent No. 5,155,034, entitled ``Three-Dimensional 
Cell to Tissue Assembly Process;'' U.S. Patent No. 5,155,035, entitled 
``Method for Culturing Mammalian Cells in a

[[Page 56017]]

Perfused Bioreactor;'' U.S. Patent No. 5,308,764, entitled ``Multi-
Cellular Three-Dimensional Living Mammalian Tissue;'' U.S. Patent No. 
5,496,722, entitled ``Method for Producing Non-Neoplastic, 3-
Dimensional Mammalian Tissue and Cell Aggregates under Microgravity 
Culture Conditions and the Products Produced Thereby;'' U.S. Patent No. 
5,627,021, entitled ``Multi-Cellular, Three-Dimensional Living 
Mammalian Tissue;'' U.S. Patent No. 5,846,807, entitled ``Media 
Compositions for Three Dimensional Mammalian Tissue Growth Under 
Microgravity Culture Conditions;'' U.S. Patent No. 5,858,783, entitled 
``Production of Normal Mammalian Organ Culture Using a Medium 
Containing MemAlpha, Leibovitz L-15, Glucose Galactose Fructose;'' U.S. 
Patent No. 5,851,816, entitled ``Cultured High-Fidelity Three 
Dimensional Human Urogenital Tract Carcinomas and Process;'' and U.S. 
Patent No. 6,117,674, entitled ``Horizontal Rotating-Wall Vessel 
Propagation in Vitro Human Tissue Models; `` and pending patent 
application identified as NASA Case No. MSC-22633-2, ``Growth 
Stimulation of Biological Cells and Tissue by Electromagnetic Fields 
and Uses Thereof.'' Each of the above U.S. Patents and the patent 
application are assigned to the United States of America as represented 
by the Administrator of the National Aeronautics and Space 
Administration. Written objections to the prospective grant of a 
license should be sent to the Johnson Space Center.

DATES: Responses to this notice must be received by October 14, 2003.

FOR FURTHER INFORMATION CONTACT: James Cate, Patent Attorney, NASA 
Johnson Space Center, Mail Stop HA, Houston, TX 77058-8452; telephone 
(281) 483-1001.

    Dated: September 23, 2003.
Robert M. Stephens,
Deputy General Counsel.
[FR Doc. 03-24531 Filed 9-26-03; 8:45 am]
BILLING CODE 7510-01-P